SCHEMBL3899778

SCHEMBL3899778

NC(=O)c1cc(N)ccc1C(=O)N1CCCCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.60
KDM4E B2RXH2 2/20 0.58
GFER P55789 2/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
MAPT P10636 2/20 0.58
THRB P10828 1/20 0.58
ALOX15 P16050 1/20 0.58
YWHAG P61981 1/20 0.58
HSD17B10 Q99714 1/20 0.58
HPGD P15428 7/20 0.46
ALDH1A1 P00352 1/20 0.46
HSD11B1 P28845 1/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
USP2 O75604 1/20 0.43
HSP90AA1 P07900 1/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
CCKBR P32239 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3899784 0.83 L3MBTL3 (0.54) HTTKDM4EGFERMEN1KMT2A
SCHEMBL3900298 0.83 RAB9A (0.52) KDM4EMEN1KMT2AALOX15HSD17B10
SCHEMBL3895784 0.83 HPGD (0.53) HTTMEN1KMT2AHPGDALDH1A1
SCHEMBL4506300 0.83 MAP2K2 (0.45) HTTMEN1KMT2AMAPTHPGD
SCHEMBL3911601 0.83 MAP2K2 (0.45) HTTMEN1KMT2AMAPTHPGD
SCHEMBL4506867 0.83 ALDH1A1 (0.56) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL3901377 0.83 RAB9A (0.52) KDM4EMEN1KMT2AALOX15HSD17B10
SCHEMBL3901908 0.83 ALDH1A1 (0.56) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL3901241 0.83 HPGD (0.51) KDM4EMEN1KMT2AHPGDALDH1A1
SCHEMBL17774874 0.82 HSP90AA1 (0.55) HTTKDM4EGFERMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7241759-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-10 US claimed
US-7550492-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2009-06-23 US disclosed
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-29 US disclosed
US-7241759-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-10 US disclosed
US-20040224983-A1 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA, N.V. (BE) 2004-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS CCKBR, CCKAR, GIPR HTT 2234/4885KDM4E 4124/4885GFER 4634/4885
US-20040224983-A1 Benzo[1,2,5]thiadiazole compounds CCKBR, CCKAR, BRSK2 HTT 3165/4885KDM4E 3591/4885GFER 4509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.